Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies - Top-Institutions - MDSpire

Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies

  • By

  • Peng Tian

  • Liping Wang

  • Tianjiao He

  • Qiurong Zhang

  • Yingying Cai

  • May 14, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    NYU Langone Hospitals (NYU Langone Health)
    NYU Langone Hospitals (NYU Langone Health)

    New York, New York

    Key Differentiators

    • Cardiology

  • #2

    The Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai (Mount Sinai Heart)
    The Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai (Mount Sinai Heart)

    New York, New York

    Key Differentiators

    • Cardiology

  • #3

    Heart Centre of the University Hospital of Cologne
    Heart Centre of the University Hospital of Cologne

    Cologne, North Rhine-Westphalia

    Key Differentiators

    • Cardiology

  • #4

    National Institute for Health Research Leicester Biomedical Research Centre
    National Institute for Health Research Leicester Biomedical Research Centre

    Leicester, England

    Key Differentiators

    • Cardiology

  • #5

    British Heart Foundation Centre of Research Excellence
    British Heart Foundation Centre of Research Excellence

    Leicester, England

    Key Differentiators

    • Cardiology

Original Source(s)

Impact of frailty on post-procedural adverse outcomes in older adults aged ≥75 years undergoing percutaneous coronary intervention: a systematic review of observational studies

  • by Peng Tian, Liping Wang, Tianjiao He, Qiurong Zhang, Yingying Cai

  • May 14, 2026

Related Content

New Label Expansion in Generalized Myasthenia Gravis

Phase 3 ADAPT SERON data supported efgartigimod use across antibody subtypes often underrepresented in trials.

Baptist Health Miami Neuroscience Institute Advances Parkinson’s Disease Imaging With Specialized MRI Protocol

Diagnosing Parkinson’s disease has long depended primarily on clinical expertise — careful neurologic examination, longitudinal symptom assessment and the nuanced interpretation of movement abnormalities.

  • by

  • May 11, 2026

  • 5 min
Innovative, Minimally Invasive Treatment for Drug-Resistant Epilepsy

Epilepsy remains a life-altering condition, particularly due to the unpredictable nature of seizures and their cumulative impact on cognition, independence and quality of life.

  • by

  • May 8, 2026

  • 5 min